|
| Press Releases |
|
 |
|
| Thursday, June 16, 2016 |
|
|
China City Construction Announces 2015/16 Annual Results |
China City Construction Group Holdings Limited ("China City Construction" or "the Group") (stock code: 00711) announces its annual results for the year ended 31 March 2016.
more info >> |
|
| Wednesday, June 15, 2016 |
|
|
中国城建公布2015/16全年业绩 |
中国城建集团股份有限公司（「中国城建」或「集团」）（股票代号：00711）宣布其截至2016年3月31日止年度业绩。
more info >> |
|
|
中國城建公佈2015/16全年業績 |
中國城建集團股份有限公司（「中國城建」或「集團」）（股票代號：00711）宣布其截至2016年3月31日止年度業績。
more info >> |
|
|
China City Construction Announces 2015/16 Annual Results |
China City Construction Group Holdings Limited ("China City Construction" or "the Group") (stock code: 00711) announces its annual results for the year ended 31 March 2016.
more info >> |
|
| Wednesday, April 27, 2016 |
|
|
中城建公布主要股东惠农基金持股量增至99% 市场反应正面显示投资者对后续发展充满信心 |
| 中国城市建设控股集团有限公司(「中城建」或「集团」)早前公布，惠农基金已成为集团的99%股东，而中国城市发展研究院有限公司持有集团的股权已由100%降至1%。 more info >> |
|
|
中城建公佈主要股東惠農基金持股量增至99% 市場反應正面顯示投資者對後續發展充滿信心 |
| 中國城市建設控股集團有限公司(「中城建」或「集團」)早前公佈，惠農基金已成為集團的99%股東，而中國城市發展研究院有限公司持有集團的股權已由100%降至1%。 more info >> |
|
| Monday, March 7, 2016 |
|
|
俊和改名为中国城建集团股份 |
俊和发展集团有限公司(「集团」) (股份代号:00711)董事会欣然宣布，集团的英文名称更改为「China City Construction Group Holdings Limited」，中文名称则更改为「中国城建集团股份有限公司」。
more info >> |
|
|
俊和改名為中國城建集團股份 |
和發展集團有限公司(「集團」) (股份代號:00711)董事會欣然宣佈，集團的英文名稱更改為「China City Construction Group Holdings Limited」，中文名稱則更改為「中國城建集團股份有限公司」。
more info >> |
|
|
Chun Wo Renamed as China City Cons |
The Board of Directors of Chun Wo Development Holdings Limited (the "Group") (stock code: 00711) is pleased to announce that the English name of the Group is changed to "China City Construction Group Holdings Limited"; while the Chinese name of the Group is changed to "China City Construction Group Holdings Limited".
more info >> |
|
| Tuesday, December 29, 2015 |
|
|
俊和获10亿港元银团贷款 |
| 俊和发展集团有限公司（「俊和」或「集团」）（股份代号：00711）今天公布，集团与三家银行订立10亿港元的定期贷款及循环信贷融资协议。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 6, 2026 15:55 HKT/SGT
|
|
|
Muyuan Foods Makes Hong Kong Debut Today: Strong Cornerstone Investor Backing Fuels Rapid Earnings Growth, Embarking on New Journey of Internationalization
Feb 6, 2026 15:40 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 15:17: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
HKTDC to host world's largest one-stop jewellery marketplace
Feb 6, 2026 14:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 14:44 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
